Matterhorn Biosciences Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Employees
-
41
- Latest Deal Type
-
Liquidation
Matterhorn Biosciences General Information
Description
Developer of M-TCR cell therapies designed to focus on the discovery of cellular therapies targeting the MR1 molecule. The company's therapies offer will develop treatments based on T cells that target metabolites, like sugars, present in cancer cells by a molecule called MR1 along with a library of T-cell receptors that can be attached to MR1T cells that recognize different metabolites, enabling physicians and doctors to recognize and kill a wide range of tumors of various tissue origins.
Contact Information
Website
www.matterhornbiosciences.comCorporate Office
- Aeschenvorstadt 36
- 4051 Basel
- Switzerland
Corporate Office
- Aeschenvorstadt 36
- 4051 Basel
- Switzerland
Matterhorn Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Bankruptcy: Liquidation | 27-Apr-2024 | Completed | Bankruptcy: Liquidation | |||
| 2. Seed Round | 05-Aug-2020 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Matterhorn Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference |
Matterhorn Biosciences Patents
Matterhorn Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023001982-A1 | Mr1 ligands and pharmaceutical compositions for immunomodulation | Inactive | 21-Jul-2021 |
Matterhorn Biosciences Signals
Matterhorn Biosciences FAQs
-
When was Matterhorn Biosciences founded?
Matterhorn Biosciences was founded in 2020.
-
Where is Matterhorn Biosciences headquartered?
Matterhorn Biosciences is headquartered in Basel, Switzerland.
-
What is the size of Matterhorn Biosciences?
Matterhorn Biosciences has 41 total employees.
-
What industry is Matterhorn Biosciences in?
Matterhorn Biosciences’s primary industry is Drug Discovery.
-
Is Matterhorn Biosciences a private or public company?
Matterhorn Biosciences is a Private company.
-
What is Matterhorn Biosciences’s current revenue?
The current revenue for Matterhorn Biosciences is .
-
How much funding has Matterhorn Biosciences raised over time?
Matterhorn Biosciences has raised $30M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process